The upcoming Xtalks webinar, scheduled for July 22, 2026, aims to bridge the gap between high-level oncology data and operational execution. The session features a panel of industry leaders, including Dannelle Palmer of Humaneva, Scott Schliebner and Dr. Julio A. Peguero of P1 Pratia Oncology, and Dr. Brandon Fletcher of Kapadi. They will dissect how emerging evidence—ranging from bispecific antibodies to genomic-informed care—necessitates a redesign of patient selection, safety oversight, and recruitment strategies.
In section Releases
Translating ASCO 2026 Breakthroughs into Clinical Trial Strategy
ASCO 2026 signaled a definitive shift in oncology as precision medicine, immunotherapy, and AI-enabled tools converged to challenge traditional treatment paradigms. With advancements like personalized cancer vaccines and previously undruggable targets now surfacing, the pressure mounts on researchers to convert these scientific milestones into practical, efficient clinical trial protocols.
Participants will examine the intersection of sponsor objectives and site-level realities. The discussion focuses on translating complex scientific advances into tangible patient benefits while maintaining data quality in an increasingly personalized therapeutic landscape. The event starts at 10am EDT and offers a collaborative look at what sponsors, CROs, and investigators must change to keep pace with rapid oncological innovation.
Comments (0)
No comments yet. Be the first!